Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

indie Semiconductor, Inc. (INDI) SEC Filings & Earnings Calls

EquiReason read 15 indie Semiconductor, Inc. SEC filings in the last 12 months. Latest: 10-Q on 2026-08-07 — indie Semiconductor reported Q2 2026 revenue of $64.0M, up 24% YoY, but gross margin declined and operating cash burn increased..

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

INDIindie Semiconductor, Inc.Follow INDI — free
Semiconductors · Technology
—
Price chart with a free account
Market cap
377.8M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

7 Aug 202610-Qindie Semiconductor reported Q2 2026 revenue of $64.0M, up 24% YoY, but gross margin declined and operating cash burn increased.earningsopen

Figures in the filing · each found in the filing text

Total revenue · Q2-2026$64M+24% y/y
Product revenue · Product · Q2-2026$61M+22% y/y
Contract revenue · Contract · Q2-2026$4M+83% y/y
Cost of goods sold · Q2-2026$41M+33% y/y
Research and development expense · Q2-2026$38M-2% y/y
Selling, general, and administrative expense · Q2-2026$20M+11% y/y
Net loss · H1-2026$-86M+9% y/y
Cash and cash equivalents · 2026-06-30$149M
Operating cash flow · H1-2026$-51M+39% y/y

Risks flagged

Negative operating cash flow and increasing cash burn

“Net cash used in operating activities for the six months ended June 30, 2026 was $51.0 million, compared to $36.6 million for the six months ended June 30, 2025, an increase of $14.4 million or 39%.”

High debt obligations with $427.9M total debt due

“Total contractual obligations $ 20,244 $ 73,386 $ 408,513 $ 2,146 $ 504,289” · word for word

Gross margin compression from product mix

“Cost of goods sold for the three months ended June 30, 2026 was $40.9 million, compared to $30.7 million for the three months ended June 30, 2025. The increase of $10.2 million or 33% was primarily due to an increase of $9.9 million increase in volume of products sold and partially offset by a decrease of $1.1 million resulting from product mix change.” · word for word
Read the original on SEC EDGAR ↗
6 Aug 20268-K · 2.02, 7.01Revenue $64M (+24% y/y); GAAP Operating Loss $-35M (-18% y/y); Non-GAAP Operating Loss $-9M (-39% y/y); Guidance: Q3 2026 revenue $67-73M, midpoint +30% YoYearningsopen

Figures in the filing · each found in the filing text

Revenue · Q2-2026$64M+24% y/y
GAAP Operating Loss · Q2-2026$-35M-18% y/y
Non-GAAP Operating Loss · Q2-2026$-9M-39% y/y
GAAP Loss Per Share · Q2-2026$-0.17
Non-GAAP Loss Per Share · Q2-2026$-0.05
Q3 2026 Revenue Guidance (Midpoint) · Q3-2026$70M+30% y/y

Guidance

Q3 2026 revenue $67-73M, midpoint +30% YoY

Q3 revenue guidance implies accelerating growth to 30% YoY from Q2's 24%.

Risks flagged

Still loss-making; GAAP op loss $35.1M.

“GAAP operating loss $35.1M.”
Read the original on SEC EDGAR ↗
22 Jun 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open

Risks flagged

Loss of co-founder and president may affect engineering execution and strategic continuity, though transition to technical advisor role mitigates risk.

“Dr. Aoki has been with indie since its inception and is renowned as one of the Company’s co-founders, serving as indie’s President, managing the execution of the Company’s engineering plans.” · word for word
Read the original on SEC EDGAR ↗
29 May 20268-K · 5.02, 5.07Reported the departure of a director or principal officer (CEO/CFO change); submitted matters to a vote of security holdersopen

Risks flagged

Potential shareholder dilution from increased equity plan shares.

“increase the number of shares of Class A common stock reserved for issuance thereunder by 17,000,000 shares”
Read the original on SEC EDGAR ↗
11 May 202610-QTotal revenue $55M (+3% y/y); Product revenue $52M (+2% y/y); Contract revenue $4M (+6% y/y)open

Figures in the filing · each found in the filing text

Total revenue · Q1-2026$55M+3% y/y
Product revenue · Q1-2026$52M+2% y/y
Contract revenue · Q1-2026$4M+6% y/y
Net loss · Q1-2026$-47M
Operating cash flow · Q1-2026$-22M
Cash and cash equivalents · Q1-2026$185M
Share-based compensation · Q1-2026$20M
Depreciation and amortization · Q1-2026$11M

Risks flagged

Debt Refinancing Risk

“Loss from extinguishment of debt of $3.7 million resulted from the repurchase of our 2027 Notes” · word for word

Negative Operating Cash Flow

“Net cash used in operating activities was $22.1 million” · word for word

Fair Value Volatility from Contingent Consideration

“net loss from change in fair value of our contingent considerations and acquisition-related holdbacks of $1.1 million” · word for word
Read the original on SEC EDGAR ↗
11 May 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen

Risks flagged

Acquisition integration risk and regulatory approval uncertainty.

“The Acquisition is subject to customary closing conditions, including regulatory approvals, and is expected to close in the third quarter of 2026.”
Read the original on SEC EDGAR ↗
7 May 20268-K · 2.02, 7.01Revenue $56M (+3% y/y); Non-GAAP operating loss $11M (-26% y/y); GAAP operating loss $39M (+0% y/y); Guidance: Q2 revenue guidance $59M-$65M, midpoint $62M, up from Q1 actual $55.5Mearningsopen

Figures in the filing · each found in the filing text

Revenue · Q1-2026$56M+3% y/y
Non-GAAP operating loss · Q1-2026$11M-27% y/y
GAAP operating loss · Q1-2026$39M0% y/y
GAAP loss per share · Q1-2026$0.21
Non-GAAP loss per share · Q1-2026$0.06
Production order value · radar chipset · Q1-2026$25M
Q2 revenue guidance midpoint · Q2-2026$62M
Core business revenue guidance · core business · Q2-2026$37M
Wuxi indie Micro revenue guidance · Wuxi indie Micro · Q2-2026$25M

Guidance

Q2 revenue guidance $59M-$65M, midpoint $62M, up from Q1 actual $55.5M

Q2 revenue guidance midpoint $62M implies ~12% sequential growth from Q1's $55.5M; management cites solid quarter, production order, and expansion into quantum and physical AI.

Risks flagged

Continued GAAP operating losses and reliance on non-GAAP metrics may mask underlying profitability challenges.

“On a GAAP basis operating loss for the first quarter of 2026 was $38.9 million, the same as the prior year period.” · word for word

Guidance provided on non-GAAP basis only, limiting comparability and transparency.

“We provide guidance on a non-GAAP basis only because certain information necessary to reconcile such results and guidance to GAAP is difficult to estimate and dependent on future events outside of our control.” · word for word
Read the original on SEC EDGAR ↗
17 Apr 2026DEF 14AProxy statement filed for annual shareholder meeting; no material event.SEC ↗
18 Mar 20268-K · 8.01indie Semiconductor sold $150M 4.00% Convertible Senior Notes due 2031, plus $20.5M greenshoe exercised, netting ~$20M additional proceeds.open

Figures in the filing · each found in the filing text

Aggregate Principal Amount of Notes Issued · Q1-2026$21M
Net Proceeds · Q1-2026$20M

Risks flagged

Increased debt and potential dilution from convertible notes; interest expense and conversion risk.

“Additional $20.5M principal of 4.00% Convertible Senior Notes due 2031; net proceeds ~$20M.”
Read the original on SEC EDGAR ↗
6 Mar 20268-K · 1.01, 2.03, 3.02, 8.01indie Semiconductor priced $150M convertible senior notes due 2031, a debt financing event with no immediate earnings impact.open

Figures in the filing · each found in the filing text

Convertible Notes Principal Amount · 2026-03-03$150M
Convertible Note Coupon · 2026-03-034.0%

Risks flagged

Increased leverage and potential dilution from convertible notes.

“$150M convertible notes due 2031; conversion could dilute existing shareholders.”
Read the original on SEC EDGAR ↗
27 Feb 202610-KRevenue from outside US 85; Revenue from Greater China 47; Revenue from Aptiv 6open

Figures in the filing · each found in the filing text

Revenue from outside US · geography · FY202585.0%
Revenue from Greater China · geography · FY202547.0%
Revenue from Aptiv · customer · FY20256.0%

Risks flagged

Wuxi divestiture failure risk

“The failure to complete the Wuxi Divestiture, or completion on terms that are less favorable than anticipated, could have a material adverse effect on our reported financial results.” · word for word

Tariff-induced demand destruction

“In 2025, multiple OEMs announced reductions in vehicle production, temporary layoffs, or adjustments to shipments in response to tariff developments and related uncertainty.” · word for word

Export control revenue loss

“The U.S. government has continued to expand export controls restricting the ability to send certain products and technology related to semiconductors, semiconductor manufacturing, AI chips, and advanced computing technology to certain countries, including China.” · word for word

Customer concentration risk

“sales to Aptiv, a leading Tier 1 automotive supplier, represented approximately 6%, 9% and 15% of our total revenue for the years ended December 31, 2025, 2024 and 2023, respectively. The loss of this customer would have a material adverse impact on our consolidated financial results.” · word for word
Read the original on SEC EDGAR ↗
19 Feb 20268-K · 2.02, 7.01Revenue $58M; GAAP operating loss $34M (+0% y/y); Non-GAAP operating loss $10M (-29% y/y); Guidance: Q1 2026 revenue midpoint $55M vs Q4 $58M; core business up 20% sequentially to $34M; Wuxi down to $21Mearningsopen

Figures in the filing · each found in the filing text

Revenue · Q4-2025$58M
GAAP operating loss · Q4-2025$34M0% y/y
Non-GAAP operating loss · Q4-2025$10M-29% y/y
GAAP loss per share · Q4-2025$0.16
Non-GAAP loss per share · Q4-2025$0.07
Revenue guidance midpoint Q1 2026 · Q1-2026$55M
Core business revenue guidance midpoint Q1 2026 · core business · Q1-2026$34M
Wuxi indie Micro revenue guidance Q1 2026 · Wuxi indie Micro subsidiary · Q1-2026$21M

Guidance

Q1 2026 revenue midpoint $55M vs Q4 $58M; core business up 20% sequentially to $34M; Wuxi down to $21M

Overall revenue guidance down sequentially due to Wuxi decline, but core business growing strongly; management tone positive on radar and design wins.

Risks flagged

Dependence on Wuxi subsidiary revenue which is expected to decline sequentially; macroeconomic conditions including inflation and rising interest rates could impact demand.

“We anticipate a decline in the first quarter revenue from our Wuxi indie Micro subsidiary to $21 million; macroeconomic conditions, including inflation, rising interest rates and volatility in the credit and financial markets” · word for word
Read the original on SEC EDGAR ↗
7 Nov 202510-QPotential divestiture of Wuxi subsidiary, which accounts for 43% of revenue, for approximately $135K; net loss improved year-over-year.open

Figures in the filing · each found in the filing text

Revenue · Q3-2025$54M-1% y/y
Net loss · Q3-2025$-41M
Net loss per share · Q3-2025$-0.19

Risks flagged

Revenue concentration in China

“For the three and nine months ended September 30, 2025, Wuxi accounted for 43% and 40% of indie’s consolidated revenue.” · word for word

Divestiture execution risk

“The Wuxi Divestiture is subject to regulatory approvals and shareholder approval; no assurance of completion.”

Customer concentration

“One large customer represented 12% and 11% of accounts receivable at September 30, 2025 and December 31, 2024.”
Read the original on SEC EDGAR ↗
6 Nov 20258-K · 2.02, 5.02, 7.01Revenue $54M; Non-GAAP gross margin 49.6; GAAP operating loss $38M; Guidance: Q4 revenue midpoint $57M vs Q3 $53.7Mearningsopen

Figures in the filing · each found in the filing text

Revenue · Q3-2025$54M
Non-GAAP gross margin · Q3-202549.6%
GAAP operating loss · Q3-2025$38M
Non-GAAP operating loss · Q3-2025$11M
GAAP loss per share · Q3-2025$0.19
Non-GAAP loss per share · Q3-2025$0.07
Strategic backlog · Q3-2025$7.40B
Q4 2025 revenue guidance midpoint · Q4-2025$57M
Substrate shortage revenue impact · Q4-2025$5M

Guidance

Q4 revenue midpoint $57M vs Q3 $53.7M

Q4 guidance implies sequential revenue growth; gross margin expected to decline slightly; backlog strength supports positive outlook.

Read the original on SEC EDGAR ↗
28 Oct 20258-K · 1.01, 7.01Sale price $135M; Equity interest sold 34.38open

Figures in the filing · each found in the filing text

Sale price$135M
Equity interest sold34.4%

Risks flagged

Transaction subject to shareholder approval and regulatory approvals; may not close as expected.

“Transaction subject to customary closing conditions including shareholder approval from United Faith and receipt of all required regulatory approvals.”

China market exposure remains through sales channel but equity stake is being exited.

“China remains an important market for indie, supported by its strong, independent, and well-established sales channel.” · word for word
Read the original on SEC EDGAR ↗

indie Semiconductor, Inc. — questions

What did indie Semiconductor, Inc. file recently?
15 SEC filings in the last 12 months. Latest: 10-Q on 2026-08-07 — indie Semiconductor reported Q2 2026 revenue of $64.0M, up 24% YoY, but gross margin declined and operating cash burn increased.

Every figure on this page comes from indie Semiconductor, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.